查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595208

肠外营养市场：按营养类型、剂型和最终用户划分 - 全球预测 2025-2030

Parenteral Nutrition Market by Nutrient Type (Amino Acids, Carbohydrates, Electrolytes), Dosage Form (Ampules, Bags, Bottles), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肠外营养市场价值为76.7亿美元，预计到2024年将达到83.3亿美元，复合年增长率为8.66%，到2030年将达到137.3亿美元。

肠外营养 (PN) 是指绕过胃肠道，将营养物质直接输送到血液中，适用于通常因医疗状况而无法摄取或吸收足够营养物质的患者。患有胃肠道疾病的患者、经历治疗副作用的肿瘤患者以及需要生长和发育必需营养素的早产儿也需要 PN。 PN 主要在医院、门诊诊所和家庭医疗机构进行。在医疗保健技术创新和需要长期营养支持的慢性病盛行率上升的推动下，市场需求不断增长。主要成长动力包括营养不良和胃肠道疾病发生率上升、先进的医疗基础设施以及经常需要营养干预的人口老化。潜在的商机在于开发更有效率、更安全的 PN 配方，并增强针对患者的客製化能力。开拓医疗保健基础设施正在开发的新兴市场也是一个重要的成长机会。然而，PN 解决方案的高成本、复杂的监管核准以及感染疾病和代谢异常等併发症的风险等挑战正在阻碍市场扩张。 PN 的创新可能会集中在提高营养素的生物利用度、降低医疗保健相关风险以及采用数位健康技术来更好地监测和管理。利用先进的资料分析和遗传资讯探索个人化营养解决方案是一个有前景的市场成长领域。市场竞争激烈，主要企业在不断创新，以提高产品的有效性和安全性。对于希望在不断变化的环境中取得成功的企业来说，及时了解监管环境的变化和技术进步至关重要。总之，如果企业能够透过策略创新并向开拓地区扩张来克服现有挑战，PN 市场潜力巨大。

主要市场统计
基准年[2023] 76.7亿美元
预测年份 [2024] 83.3亿美元
预测年份 [2030] 137.3亿美元
复合年增长率（%） 8.66%

市场动态：快速发展的肠外营养市场的关键市场洞察

供需的动态交互作用正在改变肠外营养市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 肾臟病、肝病和癌症等慢性疾病的盛行率
    • 老年人口和营养不良人口比例不断增加
    • 世界各地的高出生率和早产
  • 市场限制因素
    • 严格的政府法规对肠外营养核准
  • 市场机会
    • 创新的肠外和经肠营养治疗
    • 肠外营养技术发展
  • 市场挑战
    • 与肠外营养相关的复杂性

波特五力策略工具驾驭肠外营养市场

波特的五力架构是了解肠外营养品市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肠外营养市场的外部影响

外部宏观环境因素在塑造肠外营养补充品市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解肠外营养市场的竞争状况

对肠外营养补充剂市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵肠外营养市场供应商绩效评估

FPNV定位矩阵是评估肠外营养市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了肠外营养市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，肠外营养市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肾臟病、肝病和癌症等慢性疾病的盛行率
      • 老年人口增加及营养不良
      • 全球高出生率和早产率呈上升趋势
    • 抑制因素
      • 严格的政府法规对肠外营养核准
    • 机会
      • 创新的肠外和经肠营养治疗
      • 肠外营养技术发展
    • 任务
      • 与肠外营养相关的复杂性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依营养类型分類的肠外营养市场

  • 胺基酸
  • 碳水化合物
  • 电解质
  • 脂质
  • 综合维他命组合和微量元素

第七章依剂型分類的肠外营养市场

  • 安瓿
  • 包包
  • 瓶子
  • 管瓶

第八章 肠外营养市场：依最终用户分类

  • 诊所
  • 医院
  • 长期照护服务提供者

第九章美洲肠外营养市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太肠外营养市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲肠外营养市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • ACULIFE HEALTHCARE PRIVATE LIMITED
  • ALBERT DAVID LIMITED by Kothari Group
  • Amanta Healthcare Ltd.
  • AMINO GmbH
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Claris Lifesciences Limited
  • Evonik Industries AG
  • Fresenius Kabi AG
  • Grifols SA
  • Hamilton Bonaduz AG
  • ICU Medical, Inc.
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Well Pharma Medical Solutions LLC
Product Code: MRR-036C5CF3B549

The Parenteral Nutrition Market was valued at USD 7.67 billion in 2023, expected to reach USD 8.33 billion in 2024, and is projected to grow at a CAGR of 8.66%, to USD 13.73 billion by 2030.

Parenteral nutrition (PN) involves delivering nutrients directly into the bloodstream, bypassing the gastrointestinal tract, usually for patients unable to ingest or absorb enough nutrients due to medical conditions. The necessity of PN extends to patients with gastrointestinal disorders, oncology patients experiencing side effects from their treatment, and premature infants who require essential nutrients for growth and development. PN is primarily applied in hospitals, outpatient clinics, and home healthcare settings. Driven by innovations in healthcare technology and the rising prevalence of chronic diseases requiring long-term nutritional support, the market sees growing demand. Key growth drivers include the increasing rate of malnutrition and gastrointestinal diseases, advanced healthcare infrastructure, and a rise in the aging population that often requires nutritional interventions. Potential opportunities lie in the development of more efficient, safer PN formulations with enhanced patient-specific customization capabilities. Expanding access to emerging markets, where healthcare infrastructure is developing, also presents a significant growth opportunity. However, challenges such as the high cost of PN solutions, complex regulatory approvals, and risks of complications like infections and metabolic abnormalities hinder market expansion. Innovations in PN might focus on improving the bioavailability of nutrients, reducing healthcare-associated risks, and employing digital health technologies for better monitoring and administration. Research into personalized nutrition solutions, utilizing advanced data analytics and genetic information, offers a promising area for market growth. The market's nature is highly competitive, with key players constantly innovating to improve product efficacy and safety. Staying abreast of regulatory changes and technological advancements will be crucial for businesses aiming to succeed in this evolving landscape. In conclusion, the PN market holds significant potential, provided companies can navigate the existing challenges through strategic innovation and expansion into untapped regions.

KEY MARKET STATISTICS
Base Year [2023] USD 7.67 billion
Estimated Year [2024] USD 8.33 billion
Forecast Year [2030] USD 13.73 billion
CAGR (%) 8.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Parenteral Nutrition Market

The Parenteral Nutrition Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
    • Increasing rate of geriatric population and malnourished individuals
    • High natality and premature births around the globe
  • Market Restraints
    • Strict government rules regarding the approval of parenteral nutrition
  • Market Opportunities
    • Innovative parenteral and enteral nutrition therapy
    • Technological developments in parenteral nutrition
  • Market Challenges
    • Associated complexities with parenteral nutrition

Porter's Five Forces: A Strategic Tool for Navigating the Parenteral Nutrition Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Parenteral Nutrition Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Parenteral Nutrition Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Parenteral Nutrition Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Parenteral Nutrition Market

A detailed market share analysis in the Parenteral Nutrition Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Parenteral Nutrition Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Parenteral Nutrition Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Parenteral Nutrition Market

A strategic analysis of the Parenteral Nutrition Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Parenteral Nutrition Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., ACULIFE HEALTHCARE PRIVATE LIMITED, ALBERT DAVID LIMITED by Kothari Group, Amanta Healthcare Ltd., AMINO GmbH, B. Braun Melsungen AG, Baxter International Inc., Claris Lifesciences Limited, Evonik Industries AG, Fresenius Kabi AG, Grifols S.A., Hamilton Bonaduz AG, ICU Medical, Inc., Otsuka Holdings Co., Ltd., Pfizer Inc., Sichuan Kelun Pharmaceutical Co., Ltd., and Well Pharma Medical Solutions LLC.

Market Segmentation & Coverage

This research report categorizes the Parenteral Nutrition Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Nutrient Type, market is studied across Amino Acids, Carbohydrates, Electrolytes, Lipids, and Multivitamin Formulations & Trace Elements.
  • Based on Dosage Form, market is studied across Ampules, Bags, Bottles, and Vials.
  • Based on End-User, market is studied across Clinics, Hospitals, and Long-Term Care Providers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
      • 5.1.1.2. Increasing rate of geriatric population and malnourished individuals
      • 5.1.1.3. High natality and premature births around the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Strict government rules regarding the approval of parenteral nutrition
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative parenteral and enteral nutrition therapy
      • 5.1.3.2. Technological developments in parenteral nutrition
    • 5.1.4. Challenges
      • 5.1.4.1. Associated complexities with parenteral nutrition
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Parenteral Nutrition Market, by Nutrient Type

  • 6.1. Introduction
  • 6.2. Amino Acids
  • 6.3. Carbohydrates
  • 6.4. Electrolytes
  • 6.5. Lipids
  • 6.6. Multivitamin Formulations & Trace Elements

7. Parenteral Nutrition Market, by Dosage Form

  • 7.1. Introduction
  • 7.2. Ampules
  • 7.3. Bags
  • 7.4. Bottles
  • 7.5. Vials

8. Parenteral Nutrition Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals
  • 8.4. Long-Term Care Providers

9. Americas Parenteral Nutrition Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Parenteral Nutrition Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Parenteral Nutrition Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. ACULIFE HEALTHCARE PRIVATE LIMITED
  • 3. ALBERT DAVID LIMITED by Kothari Group
  • 4. Amanta Healthcare Ltd.
  • 5. AMINO GmbH
  • 6. B. Braun Melsungen AG
  • 7. Baxter International Inc.
  • 8. Claris Lifesciences Limited
  • 9. Evonik Industries AG
  • 10. Fresenius Kabi AG
  • 11. Grifols S.A.
  • 12. Hamilton Bonaduz AG
  • 13. ICU Medical, Inc.
  • 14. Otsuka Holdings Co., Ltd.
  • 15. Pfizer Inc.
  • 16. Sichuan Kelun Pharmaceutical Co., Ltd.
  • 17. Well Pharma Medical Solutions LLC

LIST OF FIGURES

  • FIGURE 1. PARENTERAL NUTRITION MARKET RESEARCH PROCESS
  • FIGURE 2. PARENTERAL NUTRITION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PARENTERAL NUTRITION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PARENTERAL NUTRITION MARKET DYNAMICS
  • TABLE 7. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY LIPIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY MULTIVITAMIN FORMULATIONS & TRACE ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AMPULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY LONG-TERM CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023